Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | ||
|---|---|---|---|---|---|---|
| Plasmid | 37825 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $75 | Add to Cart | |
| AAV1 | 37825-AAV1 | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV1 trial size | 37825-AAV1.T | Virus (20 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV2 | 37825-AAV2 | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV2 trial size | 37825-AAV2.T | Virus (20 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV5 | 37825-AAV5 | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV5 trial size | 37825-AAV5.T | Virus (20 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV8 | 37825-AAV8 | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV8 trial size | 37825-AAV8.T | Virus (20 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV9 | 37825-AAV9 | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV9 trial size | 37825-AAV9.T | Virus (20 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV Retrograde | 37825-AAVrg | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV Retrograde trial size | 37825-AAVrg.T | Virus (20 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV PHP.eB | 37825-PHPeB | Virus (100 µL at titer ≥ 1×10¹³ vg/mL)and Plasmid.More Information | Add to Cart | |||
This material is available to academics and nonprofits only.
Backbone
- Vector backboneAAV with CAG promoter(Search Vector Database)
- Backbone manufacturerScott Sternson
- Backbone sizew/o insert(bp)4722
- Vector typeMammalian Expression, AAV ; Adeno-associated virus
Growth in Bacteria
- Bacterial Resistance(s)Ampicillin
- Growth Temperature30°C
- Growth Strain(s)NEB Stable
- Growth instructionsUse recombinase-free E. coli (Stbl3, XL-10, Sure2 and DH5a et.al), grow at 30C
- Copy numberLow Copy
Gene/Insert
- Gene/Insert nameGFP
- Alt nameGreen fluorescent protein
- SpeciesA. victoria
- Insert Size (bp)720
- MutationN/A
- PromoterCAG
Cloning Information
- Cloning methodRestriction Enzyme
- 5′ cloning siteBamHI(not destroyed)
- 3′ cloning siteEcoRI(not destroyed)
- 5′ sequencing primeraaagagacagcaaccagg
- 3′ sequencing primercggcttctggcgtgtgac (Common Sequencing Primers)
Resource Information
- Supplemental Documents
- pAAV-CAG-GFP.gb
- Terms and Licenses
- UBMTA
- Ancillary Agreement for Plasmids Containing FP Materials
- Industry Terms
- Not Available to Industry
- Articles Citing this Plasmid
- 12 References
Depositor Comments
PLEASE CONTACT ED BOYDEN ([email protected]) FOR DETAILS ON THIS REAGENT AND FURTHER REAGENTS IN THIS LINE.
Information for AAV1 (Catalog # 37825-AAV1)(Back to top)
Purpose
Ready-to-use AAV1 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV1 cap gene
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV1
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV1 trial size (Catalog # 37825-AAV1.T)(Back to top)
Purpose
Ready-to-use AAV1 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume20 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$100 USD for preparation of 20 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV1 cap gene
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV1
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV2 (Catalog # 37825-AAV2)(Back to top)
Purpose
Ready-to-use AAV2 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV2 cap gene
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV2
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV2 trial size (Catalog # 37825-AAV2.T)(Back to top)
Purpose
Ready-to-use AAV2 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume20 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$100 USD for preparation of 20 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV2 cap gene
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV2
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV5 (Catalog # 37825-AAV5)(Back to top)
Purpose
Ready-to-use AAV5 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV5 cap gene
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV5
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV5 trial size (Catalog # 37825-AAV5.T)(Back to top)
Purpose
Ready-to-use AAV5 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume20 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$100 USD for preparation of 20 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV5 cap gene
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV5
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV8 (Catalog # 37825-AAV8)(Back to top)
Purpose
Ready-to-use AAV8 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV8 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV8
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV8 trial size (Catalog # 37825-AAV8.T)(Back to top)
Purpose
Ready-to-use AAV8 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume20 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$100 USD for preparation of 20 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV8 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV8
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV9 (Catalog # 37825-AAV9)(Back to top)
Purpose
Ready-to-use AAV9 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV9 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV9
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV9 trial size (Catalog # 37825-AAV9.T)(Back to top)
Purpose
Ready-to-use AAV9 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume20 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$100 USD for preparation of 20 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV9 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV9
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV Retrograde (Catalog # 37825-AAVrg)(Back to top)
Purpose
Ready-to-use AAV Retrograde particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
GFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons.These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV retrograde cap gene from rAAV2-retro helper (plasmid #81070)
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV retrograde (AAVrg)
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Addgene Comments
Retrograde functionality is dependent on high viral titers. Addgene recommends not diluting your AAV preps prior to use.Data submitted about 37825-AAVrg by requesting scientist(s):
- Data 1: Guinea pig, Brain parenchyma
Information for AAV Retrograde trial size (Catalog # 37825-AAVrg.T)(Back to top)
Purpose
Ready-to-use AAV Retrograde trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
GFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons.These AAV preparations are suitable purity for injection into animals.Delivery
- Volume20 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$100 USD for preparation of 20 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV retrograde cap gene from rAAV2-retro helper (plasmid #81070)
- BufferPBS + 0.001% Pluronic F-68 + 200 mM NaCl
- SerotypeAAV retrograde (AAVrg)
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Addgene Comments
Retrograde functionality is dependent on high viral titers. Addgene recommends not diluting your AAV preps prior to use.Information for AAV PHP.eB (Catalog # 37825-PHPeB)(Back to top)
Purpose
Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA.
CAG-driven GFP expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- TiterEnter the titer here≥ 1×10¹³ vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, PHP.eB cap gene pUCmini-iCAP-PHP.eB (plasmid #103005)
- BufferPBS + 0.001% Pluronic F-68
- SerotypePHPeB (plasmid #103005)
- PurificationIodixanol gradient ultracentrifugation
- Reporter GeneGFP
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Addgene Comments
Citation Information: When using the PHP.eB serotype in future publications, please acknowledge Viviana Gradinaru and cite Chan et al., Nat Neurosci, 20(8):1172-1179. Pubmed.ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
洗涤步骤看似很无聊,其实很重要,因为如果未结合的材料(如非特异结合的抗体或检测试剂)残留在微孔板中,那么它会增加背景噪音。如有必要,可增加洗涤液中的盐浓度,这会阻止非特异结合反应。如果背景过高,而您怀疑洗涤不够时,可以尝试增加洗涤次数。封闭更关键
封闭液的作用是让不相关的蛋白占据微孔板中潜在的结合位点。这就降低了可产生信号的抗体非特异结合的机会。您当然也希望抗体只与目的蛋白结合吧。如果您的背景过高,怀疑封闭不充分,那么您可以尝试使用更高浓度的封闭液,或适当延长封闭时间。如果您一直被背景问题所困扰,那么也许您该花些时间来优化封闭液。这可能需要时间,但也是值得的。目前主要有两种类型的封闭液:蛋白和非离子型去污剂。您使用的类型须取决于多个因素,包括微孔板的表面试剂、吸附的抗原、您的抗体和检测试剂。好的封闭液应降低非特异性结合,但它不应当与抗原、抗体或检测试剂发生相互作用。
最常用的非离子型去污剂是Tween-20。这种封闭液便宜、稳定,在去除洗涤过程中的一些非特异结合上很有用。但它们只在存在时起作用,因为很容易被洗掉。因此所有洗涤液中也必须添加封闭液。请勿使用高浓度(正常浓度为0.01-0.1%),它会降低特异结合,产生假阴性。另一个选择是使用蛋白和非离子型去污剂这两种封闭液,后者可协助洗涤过程中的封闭。蛋白封闭液则有所不同,是永久的。它们与开放位点结合并封闭,同时稳定与微孔板结合的抗原分子。常用的蛋白封闭液包括牛血清白蛋白(BSA)、脱脂奶粉、正常血清和鱼明胶。血清组分的内在多样性可使它有效拦截许多不同类型的分子相互作用。不过,它的缺点在于能与Protein A和IgG抗体相互作用。解决这个问题的一种方法是使用鸡或鱼的正常血清。
抗体浓度须优化我们通常会follow师兄师姐留下来的操作步骤,但是如果试剂稍有不同,则可能需要优化抗体的量。记住,非特异的抗体结合会增加背景。为了防止这一点,切勿使用过多的一抗或二抗。
2.-20度甲醇固定20分钟后,自然、干燥 10分钟
3.PBS洗净:3min*3
4.1%Triton:25min-30min.配成50ultriton+5mlpBS
5.PBS洗净:2*5min
6.羊血清封闭:37度,20分钟
7.一抗,4度过夜,一般要大于18小时或者37度 1-2小时
8.4度 PBS洗净,3min*5次
9.二抗 37度小于一小时
血清封闭:组织切片上有剩余的位点可以与一抗非特异性结合,造成后续结果的假阳性;封闭血清一般是和二抗同一来源的,血清中动物自身的抗体,预先能和组织中有交叉反应的位点发生结合;也可以用小牛血清、BSA、羊血清等,但不能与一抗来源一致。
牛血清白蛋白(BSA)用途:
1、 在酶切反应缓冲液中加入BSA,通过提高溶液中蛋白质的浓度,对酶起保护作用。防止酶的分解和非特异性吸附,能减轻有些酶的变性,减轻不利环境因素如加热,表面张力及化学因素引起的变性的。
2 、ELISA中也常常用到,比如封闭液,样本稀释液,酶结合物稀释液都可以用BSA。
3、生化研究,遗传工程和药物研究。
胎牛血清(fbs)是一种性状、外观 浅黄色澄清、无溶血、无异物稍粘稠液体。
胎牛血清(FBS)的作用:
1、提供对维持细胞指数生长的激素,基础培养基中没有或量很少的营养物,以及主要的低分子营养物。
2、提供结合蛋白,能识别维生素、脂类、金属和其他激素等,能结合或调变它们所结合的物质活力。
3、有些情况下结合蛋白质能与有毒金属和热原质结合,起到解毒作用。
4、是细胞贴壁、铺展在塑料培养基质上所需因子来源。
5、起酸碱度缓冲液作用。
6、提供蛋白酶抑制剂,使在细胞传代时使剩余胰蛋白酶失活,保护细胞不受伤害。展开
Eli-spot分析是设计用于在单细胞悬液中计数分泌细胞因子的细胞数量的方法。这个方法的优点在于只需在体外进行很少的处理从而使细胞因子产生的分析尽可能接近于体内状况。这个技术用于测定在给予一定刺激的情况下细胞因子产生细胞的数目,以及在某种处理或病理条件下的细胞因子产生细胞的数量。
2主要原理
细胞刺激后,原位产生的细胞因子被一种特异的单抗捕获,在细胞溶解后,捕获的细胞因子与第二种生物素化的检测性抗体结合,后者进一步通过与连接碱性磷酸酶的链亲和素结合被识别。PVDF包被孔的板之后与BCIP/NBT底物作用,紫色的斑点提示单个细胞产生的细胞因子。
35×96孔试剂盒的内容物
▲捕获抗体(0.52ml),置于4℃。
▲生物素化检测抗体(冻干,重悬于0.55ml水中)。
▲抗生物素蛋白链霉素-碱性磷酸酶结合物,置于4℃。
▲牛血清白蛋白(1g),置于4℃。
▲撇去的干牛奶(1g),放于室温。
▲备用底物溶液(50ml),置于4℃。
▲96孔PVDF包被板。
▲96孔PVDF-包被板
▲细胞培养基
▲CO2孵箱
▲70%乙醇
▲Tween20
▲碱性磷酸盐缓冲液
5直接或间接Eli-spot
细胞可以在抗体包被孔中直接刺激(直接)或者首先在24孔板或细颈瓶中刺激,收获,然后种于包被孔中(间接)。
方法根据:1)被分析的细胞类型;2)预期的细胞密度。如果细胞因子产生细胞的数量很少,建议用直接法实验,但是如果细胞因子产生细胞的数量很多,最好用间接的方法。无论采用直接或间接的方法,所有刺激以后的步骤是相同的。
主要步骤:
1)96孔PVDF板首先以70%乙醇处理,然后以捕获抗体包被。
2)将细胞放入抗体包被过的含有抗原/丝裂原的微孔中,在间接法中细胞被预刺激。
3)细胞用倒置平板法去除,与生物素标记的抗体共育。
4)与结合于碱性磷酸盐的链霉亲和素反应。
5)BCIP/NTB斑点形成。
◆刺激步骤:
小鼠脾细胞在PMA和lonomycin刺激下产生IFN-γ。人的IFN-γ由PBMC在PMA和lonomycin的刺激下产生。
建议步骤:
小鼠1)分离脾细胞,ficoll。间期收获细胞。用PBS洗三次,去除ficoll。2)用培养基稀释细胞(RPMI1640含2mML_glutamine,10%灭活的胎牛血清)含1ng/mlPMA和500ng/mlionomycin(Sigma),加2×10(4)—5×10(4)细胞到抗体包被的PVDF包被板,在孵箱中培养10—15小时。对于其它刺激物孵育时间可能不同,根据细胞因子产生细胞的密度,优化条件。
人用培养基稀释细胞(RPMI1640含2mML_glutamine,10%灭活的胎牛血清)含1ng/mlPMA和500ng/mlionomycin(Sigma),加2×10(4)—5×10(4)细胞到抗体包被的PVDF包被板,在孵箱中培养10—15小时。对于其它刺激物孵育时间可能不同,根据细胞因子产生细胞的密度,优化条件。
●试剂准备
●检测抗体用0.55ml蒸馏水溶解冻干抗体,轻轻混匀溶液并等到所有冻干抗体溶解。
●抗生物素蛋白链霉素-碱性磷酸酶用含1%BSA的PBS稀释(1/1000)
●碱性磷酸盐缓冲液(10×浓缩液)
1L溶液:80gNaCL;2gKH2PO4;14.4gNa2HPO42H2O;2gKCL,加蒸馏水至1升。检查PH在7.2-7.4之间,此溶液在用之前稀释为1×溶液。
●含2%脱脂干奶粉的PBS一块板溶0.2g干粉于10ml1×PBS。
●含1%BSA的PBS一块板溶0.2g干粉于20ml1×PBS。
●含0.1%Tween的PBS一块板溶100μlTween20于100ml1×PBS。
●70%乙醇一块板以3ml蒸馏水和7ml乙醇混匀。
★试剂保存
1)如果短时间内不用,溶解的检测抗体应分装和保存于—20℃,在这种条件下,试剂可稳定保存至少一年。
2)底物缓冲液保存于4℃。
3)链霉亲和素-碱性磷酸酶保存于4℃。
Eli-spot步骤
1PVDF包被板用100ul70%乙醇室温下处理10分钟。
2倒空孔并以100ulPBS洗3次。
3将100ul捕获抗体加到10mlPBS中,混合并分至每孔中100ul,盖上板盖,放至4℃过夜。
4倒空每孔,用100ulPBS洗一次。
5每孔加100ul含2%脱脂干牛奶的PBS,盖板,室温2小时。
6在洗涤槽上轻弹板子倒空液体,并在吸水纸上吸干。
7用PBS洗一次。
8分配每孔100ul细胞悬液(含合适的细胞数和合适的刺激物浓度),细胞可以在体外预刺激(间接Eli-spot)。盖上板,放细胞于37℃CO2孵箱,合适的时间15-20小时。(在此期间不要摇动或平移平板。)
9在洗涤槽上轻弹板子倒空液体,并在吸水纸上吸干。
10每孔加100ul含0.1%Tween20的PBS,4℃放置10分钟。
11用含0.1%Tween20的PBS洗板三次。
12每一块板,稀释100ul检测抗体到10ml含1%BSA的PBS中,每孔加100ul,封闭扳子放于37℃1小时30分钟。
13倒空扳子并用含0.1%Tween20的PBS洗三次。
14每一块板,稀释10ul链霉亲和素-碱性磷酸酶复合物到10ml含1%BSA的PBS中,每孔加100ul,封闭扳子放于37℃1小时。
15倒空,用含0.1%Tween20的PBS洗三遍,反复用吸水纸吸以去尽所有残存的液体。
16每孔加100ul备用BCIP/NBT溶液。
17让反应在室温进行5-20分钟。肉眼可见小斑点形成。
18用蒸馏水洗三次。
19干燥每孔。计数斑点。注意斑点在4℃过夜后可能会变得明显,放置扳子于室温,避免直接光照。
生物素容易与蛋白质和核酸类等生物大分子结合,形成的生物素衍生物,不仅保持了大分子物质的原有生物活性,而且比恬度高,具多价性。此外,每个亲和素分子有四个生物素结合部位,可同时以多价形式结合生物素化的大分子衍生物和标记物。因此,BAS具有多级放大作用,使其在应用时可极大地提高检测方法的灵敏度。
特异性
亲和素与生物素间的结合具有极高的亲和力,其反应呈高度专一性。因此,BAS的多层次放大作用在提高灵敏度的同时,并不增加非特异性干扰。而且,BAS结合特性不会因反应试剂的高度稀释而受影响,使其在实际应用中可最大限度地降低反应试剂的非特异作用。
稳定性
亲和素结合生物素的亲和常数可为抗原-抗体反应的百万倍,二者结合形成复合物的解离常数很小,呈不可逆反应性;而且酸、碱、变性剂、蛋白溶解酶以及有机溶剂均不影响其结合。因此,BAS在实际应用中,产物的稳定性高,从而可降低操作误差,提高测定的精确度。
普适性
生物素-结合素系统的多功能性还能提供一套统一的研究方法。例如对于某待测分子,已经得到了对于该分子的生物素标记抗原,那么配合结合亲和素的胶体金可以在电镜下观测,配合结合荧光标记的亲和素可以使用流式细胞仪筛选,配合连接到酶的亲和素可以进行ELISA等免疫组化实验。
细胞培养瓶(板)生长面积容量与细胞数(大约)
96孔板 4~5X10 4 35mm培养皿 1X10 6
48 孔板 1.3X10 5 60mm培养皿 2.6X10 6
24孔板 2.5X10 5 100mm培养皿 7X10 6
12孔板 5X10 5 150mm培养皿 1.8X10 7
6孔板 1.2X10 6
细胞瓶面积 容量 工作体积 细胞数目
612.5cm2 25ml 2ml 5X10 5
25cm2 50ml 5ml 1X10 68
35cm2 75ml 10ml 2X10 6
75 cm2 250ml 15ml X10 6
150cm2 700ml 40ml 1.1X10 7
补充:不同孔板所加培养液的液面都不宜太深,一般在2~3mm范围,结合不同孔的底面积就可算出各培养孔的适宜加液量(参考下表)。若加液量过多会影响气体(氧气)交换,而且在搬动过程中易溢出造成污染。具体所加细胞密度依实验的目的不同灵活掌握。

